Intracoronary ketanserin augments coronary collateral blood flow and decreases myocardial ischemia during balloon angioplasty

Cardiovascular Drugs and Therapy

Volumn 13, Issue 5, 1999, Pages 415-422

  Kyriakides, Zenon S ^a   Sbarouni, Eftihia ^a   Nikolaou, Nikolaos ^a   Antoniadis, Aias ^a   Th Kremastinos, Dimitrios ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Balloon angioplasty; Coronary collateral flow; Ketanserin; Myocardial ischemia

Indexed keywords

KETANSERIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOPLASTY, BALLOON; ANTIHYPERTENSIVE AGENTS; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KETANSERIN; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 0032848325     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007851906207     Document Type: Article

References (25)

1. Golino P, Piscione F, Willerson JT, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atheroselerosis and control patients. N Engl J Med 1991;324:641-648.
2. 2 on blood flow through moderately well developed coronary collateral vessels. J Am Coll Cardiol 1992;19:687-693.
3. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Masseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991;324:648-654.
4. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med 1994:330:523-528.
5. Doucette JW, Corl DP, Payne HP, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-1911.
6. Donohue TJ, Kern MJ, Aguire FV, Bell C, Penick D, Ofili E. Comparison of hemodynamic and pharmacologic perturbations of coronary collateral flow velocity in patients during angioplasty. J Am Coll Cardiol 1992;19:383A.
7. Yamada T, Okamoto M, Sueda T, Hashimoto M, Kajiyama G. Relation between collateral flow assessed by Doppler guide wire and angiographic collateral grades. Am Heart J 1995; 130:32-37.
8. Pijls NHJ, Van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;86:1354-1367.
9. Pijls NHJ, De Bruyne B. Assessment of collateral blood flow by coronary pressure measurement, In: Coronary Pressure. London: Kluwer Academic Publishers, 1997: 237-259.
10. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-592.
11. Uehata A, Matsuguchi T, Bittl JA, et al. Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation 1993;88:724-729
12. Quigley PJ, Hinohara T, Phillips HR, et al. Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans. Circulation 1988;78:1128-1134.
13. Kaltenbach M, Beyer J, Walter S, Klepzig H, Schmidts L. Prolonged application of pressure in transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1984; 10:213-219.
14. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J Am Coll Cardiol 1992;20:578-586.
15. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-1142.
16. Perry RA, Seth A, Hunt A, et al. Balloon occlusion during coronary angioplasty as a model of myocardial ischaemia: Reproducibility of sequential inflations. Eur Heart J 1989; 10:791-800.
17. Schaub RG, Meyers KM, Sande R. Serotonin as a factor in depression of collateral blood flow following experimental arterial thrombosis. J Lab Clin Med 1977;90:645-653.
18. Verheyen A, Vlaminckx E, Lauwers F, VanDen Broeck C, Wouters L. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin. Arch Int Pharmacodyn Ther 1984;270:280-298.
19. 2 receptor antagonist. Arch Int Pharmacodyn Ther 1984;270:268-279.
20. Hollenberg NK. Collateral arterial tree responses to serotonin. J Cardiovasc Pharmacol 1987;10(Suppl 3):S35-S38.
21. McFadden EP, Bauters C, Lablanche JM, Quandalle P, Leroy F, Bertrand ME. Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation 1993;88:2076-2085.
22. 2 receptor antagonist: A measure of improved collateral and microcirculatory flow. J Cardiovasc Pharmacol 1985;7 (Suppl 7):S92-S94.
23. Adams GA, Feuerstein IA. Platelet accumulation on collagen drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels. Thromb Haemost 1984;52:45-49.
24. Tanaka T, Fujita M, Nakae I, et al. Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina. J Am Coll Cardiol 1998;32;1982-1986.
25. Robertson JI, Stott DJ, Ball SG, Antihypertensive mode of action of ketanserin. J Cardiovasc Pharmacol 1987;10: S45-S47.